within Pharmacolibrary.Drugs.ATC.B;

model B01AA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Tioclomarol is a synthetic anticoagulant of the coumarin class, similar to warfarin. It was primarily developed and used as a rodenticide. Tioclomarol acts as a vitamin K antagonist, inhibiting the synthesis of vitamin K-dependent clotting factors. It is not approved for human therapeutic use and is not used in clinical medicine today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models for tioclomarol in humans or animals were identified in scientific literature as of June 2024. The following values are empty as there are no available estimates.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B01AA11;
